Recent advances and developments in COVID‐19 in the context of allergic diseases

Background Since the first reports of coronavirus disease 2019 (COVID‐19) in Wuhan, China, in December 2019, there have been 198 million confirmed cases worldwide as of August 2021. The scientific community has joined efforts to gain knowledge of the newly emerged virus named severe acute respirator...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Clinical and translational allergy Ročník 11; číslo 7; s. e12065 - n/a
Hlavní autori:	Ding, Mei, Dong, Xiang, Sun, Yuan‐li, Sokolowska, Milena, Akdis, Mübeccel, Veen, Willem, Azkur, Ahmet Kursat, Azkur, Dilek, Akdis, Cezmi A., Gao, Ya‐dong
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England John Wiley & Sons, Inc 01.09.2021 John Wiley and Sons Inc Wiley
Predmet:	Allergies allergy Asthma Biomarkers Clinical outcomes Coronaviruses COVID-19 Cytokines Disease Gene expression Genotype & phenotype Hay fever Immunotherapy Impfung Infections Inflammation mechanism Mechanismen Medical supplies Mortality Pandemics Proteins Review Rhinitis Schlüsselwörter: Allergie Severe acute respiratory syndrome coronavirus 2 Therapie treatment vaccination Viral infections Viruses United Kingdom > UK COVID-19 Mechanismen treatment Therapie Impfung Schlüsselwörter: Allergie allergy mechanism vaccination
ISSN:	2045-7022, 2045-7022
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!